The purpose of this research study is to: test the safety and tolerability of the study drug LB54640 at increasing doses, to see how your body breaks down the study drug and removes it from the body, and to see how the study drug affects body composition, blood sugar, body weight, cholesterol, triglycerides, mood, food intake, and appetite.
Participation in this study will last approximately 41 days plus up to 30 days for screening. The screening procedures may be done at a single visit or more than one visit. You will: stay in-house at the study site for 7 days in a row, return for an outpatient visit on Day 14 and Day 21, stay in-house at the study site for 7 days in a row, then return for a final follow-up visit about 8 days after you complete the second in-house stay.
- Male or Female:
- Between the ages of 18 and 70
- BMI of 27 or higher
- HbA1c lower than 6.5%
- Daily use of no more than 10 cigarettes/day, or 2 cigars/day, or equivalent use of any tobacco product within 6 weeks prior to Screening and able to refrain from smoking during the study is permitted
Study Participants may receive:
- Compensation of up to $3,925 if all visits are complete
Sign Up Today
Each study has a set of criteria to determine a study participant’s eligibility. Please fill out our confidential online application. Our highly trained study participant recruiters will review your application and contact you if you may be a fit for a current or future study. Incomplete applications may not be seen—please ensure all applicable fields are filled out.
Get To Know Us
ProSciento’s clinical research facility is located 10 miles south of San Diego’s downtown area, 13 miles south of the San Diego International Airport, and 7 miles north of the US/Mexico border.
An on-site parking lot and parking garage are available and located within convenient access to public transportation. Additional transportation options may also be available at no-cost to study participants. Please ask your study participant recruiter for more information.